Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Mauritius

Mauritius

The Other Vaccines market in Mauritius is expected to achieve a revenue of US$3.65m in 2024.
With an annual growth rate (CAGR 2024-2029) of 11.32%, the market volume is projected to increase to US$6.24m by 2029.
In terms of global comparison, United States is anticipated to generate the highest revenue, reaching US$24,730.00m in 2024.
Mauritius is witnessing a rising demand for other vaccines, driven by its comprehensive healthcare system and a proactive approach towards public health.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Mauritius has been experiencing steady growth in recent years.

Customer preferences: Mauritius has a well-established healthcare system, and the population has a high awareness of the importance of vaccination. As a result, there is a strong demand for Other Vaccines in the country. The government has also been actively promoting vaccination programs to prevent the spread of diseases.

Trends in the market: One of the key trends in the Other Vaccines market in Mauritius is the increasing adoption of new and innovative vaccines. The market has seen the introduction of several new vaccines in recent years, and there is a growing demand for these products. Another trend is the increasing availability of vaccines in rural areas, which has been made possible by the expansion of the healthcare system.

Local special circumstances: Mauritius is a small island nation with a population of just over 1.2 million people. The country has a high standard of living and a well-developed healthcare system, which has helped to drive demand for Other Vaccines. The government has also been actively promoting vaccination programs to prevent the spread of diseases.

Underlying macroeconomic factors: Mauritius has a stable economy and a favorable business environment, which has attracted investment in the healthcare sector. The government has also been investing in the healthcare system, which has helped to drive demand for Other Vaccines. Another factor is the country's strategic location, which has made it an attractive destination for medical tourism. This has helped to drive demand for Other Vaccines, as visitors to the country often require vaccinations before traveling.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.